Publications

Estimating RSV seasonality from pandemic disruptions: a modelling study.

KRAUER, F; Fjelde, TE; KOLTAI, M; HODGSON, D; Treskova-Schwarzbach, M; Harvey, C; JIT, M; Wichmann, O; Harder, T; Flasche, S;

2022

medRxiv (2022). 10.1101/2022.06.18.22276591.

RESIST2: Interventions.

Knight, G;

2022

, London School of Hygiene & Tropical Medicine (2022). 10.17037/PUBS.04669768.

The impact of local vaccine coverage and recent incidence on measles transmission in France between 2009 and 2018.

ROBERT, A; KUCHARSKI, AJ; FUNK, S;

2022

BMC Medicine, (2022).20 1 10.1186/s12916-022-02277-5.

Prevalence and risk factors for human papillomavirus infection among female sex workers in Hanoi and Ho Chi Minh City, Viet Nam: a cross-sectional study.

Pham, QD; PREM, K; Le, TA; Van Trang, N; JIT, M; Nguyen, TA; Cao, V; Le-Ha, T-D; Chu, MT N; Le, LT K; Toh, ZQ; Brisson, M; Garland, S; Murray, G; Bright, K; Dang, DA; Tran, HP; MULHOLLAND, EK;

2022

Western Pacific surveillance and response journal, (2022).13 4 10.5365/wpsar.2022.13.4.894.

"We've all got the virus inside us now": Disaggregating public health relations and responsibilities for health protection in pandemic London.

KASSTAN, B; MOUNIER-JACK, S; GASKELL, KM; EGGO, RM; MARKS, M; CHANTLER, T;

2022

Social Science and Medicine, (2022).309, 10.1016/j.socscimed.2022.115237.

Optimising health benefit packages in the era of COVID-19: A case study from Pakistan (Accepted).

TORRES RUEDA, S; Kitson, N; BOZZANI, F; SWEENEY, S; Raza, W; Murad Shah, M; NAYLOR, N; PEARSON, C; EGGO, R; Quaife, M; PROCTER, S; Huda, M; CHiL COVID Working Group,; Jit, M; VASSALL, A;

2022

(2022).

Overall and cause-specific hospitalisation and death after COVID-19 hospitalisation in England: A cohort study using linked primary care, secondary care, and death registration data in the OpenSAFELY platform.

BHASKARAN, K; RENTSCH, CT; Hickman, G; Hulme, WJ; SCHULTZE, A; Curtis, HJ; WING, K; WARREN-GASH, C; TOMLINSON, L; Bates, CJ; MATHUR, R; MacKenna, B; MAHALINGASIVAM, V; WONG, A; Walker, AJ; Morton, CE; GRINT, D; Mehrkar, A; EGGO, RM; Inglesby, P; DOUGLAS, IJ; MCDONALD, HI; Cockburn, J; WILLIAMSON, EJ; Evans, D; ... GOLDACRE, B.

2022

PLoS medicine, (2022).19 1 10.1371/journal.pmed.1003871.

The cost and cost-effectiveness of novel tuberculosis vaccines in low- and middle-income countries: a modelling study.

Portnoy, A; Clark, R; Quaife, M; WEERASURIYA, C; Mukandavire, C; Bakker, R; Deol, A; Malhotra, S; Gebreselassie, N; Zignol, M; Sim, SY; Hutubessy, RC W; Baena, IG; Nishikiori, N; JIT, M; WHITE, R; Menzies, N;

2022

medRxiv (2022). 10.1101/2022.05.04.22274654.

Estimating the cost-effectiveness of maternal vaccination and monoclonal antibodies for respiratory syncytial virus in Kenya and South Africa.

KOLTAI, M; Moyes, J; Nyawanda, B; Nyiro, J; Munywoki, P; Tempia, S; Li, X; Antillon, M; Bilcke, J; Flasche, S; Beutels, P; Nokes, J; Cohen, C; JIT, M;

2022

medRxiv (2022). 10.1101/2022.09.09.22279780.

Unmasking Pneumococcal Carriage in a High Human Immunodeficiency Virus (HIV) Prevalence Population in two Community Cohorts in South Africa, 2016-2018: The PHIRST Study.

Carrim, M; Tempia, S; THINDWA, D; Martinson, NA; Kahn, K; FLASCHE, S; Hellferscee, O; Treurnicht, FK; McMorrow, ML; Moyes, J; Mkhencele, T; Mathunjwa, A; Kleynhans, J; Lebina, L; Mothlaoleng, K; Wafawanaka, F; Gómez-Olivé, FX; Cohen, C; Von Gottberg, A; Wolter, N; PHIRST group,;

2022

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, (2022).76 3 10.1093/cid/ciac499.